Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
KATNBL1	"C15orf29, FLJ22557"	ENSG00000134152	"Katanin regulatory subunit B1 like 1"	Q9H079	15	34140674-34210096	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 75.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 46.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062573	Approved		Supported	"Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle"				"Midbody, Mitotic spindle"	"Nucleoplasm, Cleavage furrow"	"HPA062573: "	"unprognostic (5.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.94e-3)"	"unprognostic (8.00e-3)"	"prognostic unfavourable (4.60e-5)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	13.2	7.9	16.2	14.0	22.6	9.1	22.7	16.7	26.0	11.7	12.2	10.7	10.5	9.6	13.5	12.5	28.8	10.9	10.2	9.0	11.2	9.0	9.1	10.9	20.2	10.7	13.8	10.3	10.9	14.3	8.7	10.4	75.0	15.0	11.9	13.6	8.9	10.5	9.0	7.4	19.7	9.4	16.1	17.8	12.0	11.0	11.0	12.8	7.5	8.3	8.6	12.3	10.2	19.1	9.1	10.2	46.0	6.8	4.3	8.9	4.5	17.9	15.7	25.1	16.8	20.3	20.4	18.7	24.4	14.9	19.6	19.6	8.9	10.0	8.8	16.1	15.8	23.7	12.2	14.0	23.2	18.0	6.6	15.5	16.6	10.5	14.2	16.2	16.8	12.1	20.7	13.3	26.2	35.0	16.5	18.4	26.6	8.7	10.1	13.3	18.4	12.5	15.7	15.3	8.2	18.1	24.2	14.2	12.7	15.0	11.0	7.2	13.6	19.4	20.0	26.7	13.7	23.6	19.3	11.5	15.4	18.0	23.9	17.7	19.8	16.5	6.8	10.3	7.0	6.3	8.9	8.5	7.7	7.2	7.4	9.1	8.6	7.6	46.0	4.3	4.0	10.2	6.3	4.5	16.2	22.6	16.7	26.0	11.2	9.0	13.8	10.3	15.0	12.8
KIF20B	"CT90, KRMP1, MPHOSPH1, MPP1"	ENSG00000138182	"Kinesin family member 20B"	Q96Q89	10	89701610-89774939	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031263, HPA050214"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol"				"Nucleoplasm, Cytokinetic bridge"	"Midbody, Cytosol"	"HPA031263: AB_10602610, HPA050214: "	"unprognostic (2.13e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.95e-5)"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (3.06e-6)"	"unprognostic (4.22e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.43e-2)"	3.9	2.3	1.3	5.9	6.6	11.1	3.2	12.8	3.0	4.1	3.8	0.7	1.1	4.3	3.4	2.2	7.0	3.3	1.5	2.2	2.1	1.3	2.4	3.2	2.8	9.5	1.6	2.6	4.3	2.0	2.1	3.2	4.0	3.6	2.3	5.1	1.5	3.4	2.0	2.1	4.9	5.5	3.0	3.0	8.0	3.0	10.2	2.6	26.2	2.8	3.9	9.1	2.8	3.8	13.3	4.8	8.3	3.9	2.4	8.6	1.9	35.5	7.3	10.7	9.4	2.1	3.6	8.9	14.6	13.4	15.3	16.2	9.6	16.5	13.8	4.6	7.4	18.1	11.8	8.2	20.7	16.6	8.1	14.0	12.7	8.2	0.6	23.8	11.6	1.5	1.2	14.8	15.2	9.8	13.3	15.9	13.6	6.1	13.9	4.6	10.9	7.0	9.7	21.0	6.0	4.8	4.8	3.4	6.1	10.5	4.8	5.5	12.4	6.9	7.7	9.9	9.9	12.8	23.4	4.4	12.0	18.6	9.3	21.2	7.3	8.3	2.3	3.7	5.5	3.9	6.7	11.5	7.4	5.9	1.2	13.3	8.6	8.0	0.1	2.4	3.8	4.8	8.6	1.9	1.3	6.6	12.8	3.0	2.1	1.3	1.6	2.6	3.6	2.6
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898479-112029561	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.8;Hep G2: 21.6;HUVEC TERT2: 21.5;RT4: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 10.3;non-classical monocyte: 6.4"	"Lineage enriched"	"Detected in single"	48	"monocytes: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"			29000000	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: "	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favourable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	55.1	13.1	12.5	17.8	1.9	31.8	6.2	13.8	10.8	13.8	6.8	27.7	11.5	11.3	25.4	8.4	12.8	11.7	7.1	16.5	6.3	14.2	18.9	12.7	30.3	8.1	10.1	12.9	9.0	23.9	14.3	18.4	18.6	14.1	7.9	20.4	6.8	24.9	6.4	6.4	12.8	13.6	12.2	38.4	12.3	17.3	9.8	1.7	9.9	2.0	8.4	14.1	26.6	0.0	0.2	0.1	10.3	0.0	0.0	0.3	0.5	0.9	4.3	9.7	0.2	0.1	6.9	0.0	0.1	0.5	1.0	20.8	1.3	0.1	4.6	0.0	0.1	5.7	0.0	0.8	0.8	3.0	3.7	0.0	21.6	0.1	0.1	0.8	0.2	0.0	5.0	0.3	21.5	1.1	2.0	1.6	0.9	0.0	4.9	2.7	3.4	1.4	1.2	1.6	10.9	12.9	0.1	4.1	0.1	0.3	1.7	0.0	0.2	3.2	0.6	2.0	0.0	0.0	1.7	2.5	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	6.4	0.1	0.0	0.3	13.1	17.8	6.2	13.8	16.5	6.3	8.1	10.1	18.6	9.8
NEXMIF	"KIAA2022, KIDLIA, MRX98, XPN"	ENSG00000050030	"Neurite extension and migration factor"	Q5QGS0	X	74732856-74925485	"Disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;parathyroid gland: 9.0"	"Group enriched"	"Detected in some"	9	"HAP1: 6.5;Karpas-707: 10.5;SiHa: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000407	Uncertain		Supported	"Nucleoplasm,Midbody,Mitotic spindle,Cytosol"				Nucleoplasm	"Midbody, Mitotic spindle, Cytosol"	"HPA000407: "	"unprognostic (1.04e-3)"	"unprognostic (6.07e-5)"	"unprognostic (1.81e-2)"	"unprognostic (2.07e-5)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.79e-4)"	"unprognostic (6.94e-4)"	0.6	3.0	5.4	0.7	6.2	0.4	1.3	10.2	9.4	1.7	1.9	0.7	1.0	0.6	1.7	0.9	1.8	1.3	0.5	0.3	5.0	6.2	2.4	0.2	0.9	0.5	1.8	5.0	1.7	4.4	9.0	7.5	0.5	1.9	3.2	1.1	1.1	2.5	2.5	0.4	1.8	1.1	2.6	1.2	0.6	1.6	0.9	1.5	0.0	1.5	0.0	0.5	0.7	2.8	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.2	0.3	0.1	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	9.3	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	6.2	10.2	6.8	5.0	6.2	1.8	5.0	1.9	1.5
PCDHGB1	PCDH-GAMMA-B1	ENSG00000254221	"Protocadherin gamma subfamily B, 1"	Q9Y5G3	5	141350102-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 32.2;pituitary gland: 13.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.9;ASC TERT1: 7.7;T-47d: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA076182"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody"				"Vesicles, Plasma membrane"	"Nucleoplasm, Focal adhesion sites, Midbody"	"HPA008755: AB_1079577, HPA010580: , HPA076182: "	"unprognostic (1.53e-2)"	"unprognostic (1.94e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.63e-3)"	2.3	2.7	8.2	1.4	7.5	1.0	2.1	4.3	32.2	2.5	1.4	9.4	0.1	1.2	3.7	2.0	1.7	1.9	2.1	2.2	7.6	5.7	2.1	1.3	2.4	1.2	5.5	5.0	4.1	2.8	1.4	13.7	1.6	7.0	2.5	1.4	2.6	1.7	3.1	1.1	1.4	1.3	3.0	6.9	1.4	1.2	1.5	5.6	0.0	2.5	0.0	1.2	1.4	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	2.1	1.8	0.0	14.9	7.7	0.1	1.4	3.6	0.5	0.8	0.2	0.5	0.5	4.7	0.5	0.6	0.4	0.2	0.5	0.0	0.9	0.0	0.2	1.3	0.2	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.2	0.2	3.3	1.9	0.4	0.3	0.2	0.0	0.0	2.8	0.1	0.0	0.0	1.1	0.8	0.0	0.9	0.1	9.6	0.0	1.1	0.2	1.6	1.2	0.0	0.0	2.6	0.3	2.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	7.5	4.3	9.6	7.6	5.7	5.5	5.0	7.0	5.6
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652699-138834938	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 41.2;HMC-1: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody				Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: "	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	12.5	9.9	10.6	9.7	20.6	17.4	11.5	29.9	25.0	12.4	14.6	11.9	11.7	13.7	9.6	6.9	15.2	10.9	8.7	12.7	12.2	14.2	22.6	9.3	9.5	9.1	11.9	15.2	8.8	20.3	20.2	10.9	18.1	24.1	13.4	15.7	12.2	14.9	15.9	33.4	19.6	16.4	8.3	12.5	9.9	11.0	6.4	10.7	14.4	37.4	7.1	11.9	13.4	11.0	4.6	9.1	11.3	7.8	1.3	6.5	2.6	22.6	9.8	4.2	3.5	3.9	5.2	28.7	5.3	5.1	5.4	5.8	10.5	8.6	9.1	14.5	5.2	9.7	5.5	8.4	9.7	11.6	6.2	41.2	6.7	6.3	4.0	10.0	65.3	4.4	6.5	3.8	7.7	8.1	15.7	6.8	6.7	10.3	5.8	7.0	6.0	9.2	4.2	4.4	6.5	8.3	12.5	3.7	2.7	14.7	6.4	18.9	16.0	23.9	8.5	3.5	4.4	7.5	7.4	11.5	7.5	8.3	8.5	9.7	4.8	7.0	7.8	11.3	4.0	4.5	2.7	4.6	5.2	3.0	9.1	4.1	6.5	4.4	10.0	1.3	4.3	1.4	2.2	2.6	10.6	20.6	29.9	25.0	12.2	14.2	11.9	15.2	24.1	10.7
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966038-90995629	"Predicted intracellular proteins"	"Cell cycle, Cell division"		Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 18.9;T-reg: 5.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 18.9;T-cells: 5.8"	"Low region specificity"	"Detected in single"							"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"				"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	Nucleoplasm	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	3.2	2.8	3.5	13.0	3.8	43.3	3.6	12.5	5.8	3.4	9.3	1.6	0.2	6.1	3.5	4.7	15.0	2.6	2.8	3.5	5.1	4.9	2.3	1.9	5.8	9.2	3.4	4.7	3.6	3.8	1.6	1.5	10.4	5.2	2.4	9.9	2.7	3.9	1.0	2.5	9.9	6.6	5.4	3.5	5.8	5.0	44.3	0.8	44.5	1.8	15.3	16.5	3.5	4.9	0.9	2.0	18.9	0.4	2.0	5.8	0.7	32.4	39.7	33.2	22.6	3.5	6.0	17.8	46.8	27.7	51.9	39.7	26.5	31.7	12.4	18.6	29.8	44.3	37.8	20.0	49.1	22.9	41.9	25.6	51.9	24.3	0.8	12.6	22.2	1.5	2.6	29.4	30.2	29.0	21.3	26.6	48.2	28.2	12.9	19.3	13.0	17.0	13.6	41.5	16.6	23.1	24.7	30.3	24.0	44.5	24.8	16.1	29.7	25.0	17.3	34.3	30.3	28.3	67.4	8.6	22.8	15.3	15.0	31.4	52.3	18.9	0.4	2.0	0.5	0.0	0.3	0.9	1.0	1.0	1.8	0.4	0.9	0.4	0.2	2.0	0.2	2.0	5.8	0.7	3.5	3.8	12.5	5.8	5.1	4.9	3.4	4.7	5.2	0.8
RBM18	MGC2734	ENSG00000119446	"RNA binding motif protein 18"	Q96H35	9	122237624-122264839	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057281, HPA077955"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Midbody,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Midbody, Cytosol"	"HPA057281: , HPA077955: "	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.39e-3)"	"unprognostic (7.27e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"prognostic favourable (8.00e-7)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	12.8	14.8	16.5	9.1	16.5	15.1	24.6	18.1	20.3	14.4	13.4	10.5	13.7	10.4	13.6	16.2	11.8	11.6	11.7	27.2	16.7	18.6	17.3	12.2	10.7	10.9	17.8	13.2	15.1	13.7	16.0	18.2	16.2	16.3	17.2	12.6	8.2	12.6	13.9	29.4	10.1	10.8	13.2	16.0	12.4	12.3	7.6	15.0	11.9	15.3	13.5	11.1	13.0	14.4	8.7	9.5	16.0	13.0	7.7	10.0	8.2	5.8	6.1	8.4	9.3	12.5	15.4	7.4	13.3	11.0	9.2	8.5	7.0	5.8	10.2	5.8	8.6	13.8	13.1	13.9	11.6	10.5	6.0	7.6	10.2	5.9	14.0	15.2	10.6	13.1	15.8	9.6	19.7	13.1	10.4	8.1	13.7	6.4	7.9	9.4	6.5	10.2	7.0	17.5	13.9	12.8	6.6	17.7	9.3	10.0	14.2	15.1	8.2	8.6	7.2	8.6	4.9	13.7	13.0	11.8	21.7	8.6	14.2	9.4	10.3	6.8	9.2	16.0	10.0	10.5	9.6	8.7	8.9	9.7	9.5	6.0	9.3	9.7	9.7	7.7	13.0	6.9	9.1	8.2	16.5	16.5	18.1	20.3	16.7	18.6	17.8	13.2	16.3	15.0
SEPT7	"CDC10, CDC3, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Enhanced	"Nucleoli,Actin filaments,Midbody,Cytosol"			16000000	"Actin filaments"	"Nucleoli, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	35.5	28.5	89.0	26.8	77.8	31.9	29.5	41.9	81.5	35.1	28.7	54.3	11.5	15.7	37.8	36.2	31.7	25.4	34.2	47.5	86.4	58.1	24.3	21.5	28.3	38.8	79.6	66.2	42.8	11.2	22.9	31.9	41.0	72.0	28.4	28.2	9.6	14.9	29.9	21.7	29.1	20.1	42.6	76.8	29.5	18.1	19.3	98.2	33.0	22.6	17.3	41.4	36.9	24.0	40.4	24.0	47.3	24.8	69.1	56.8	48.6	36.6	17.7	45.1	29.6	50.8	52.6	23.1	47.3	43.7	40.4	34.8	27.4	28.5	34.7	32.2	48.1	27.9	31.8	31.5	57.7	23.7	16.7	27.9	24.7	14.8	29.7	33.6	30.9	34.1	24.7	31.7	31.3	42.1	21.9	27.5	65.5	17.1	33.9	56.5	48.3	25.0	35.1	42.9	19.9	39.1	27.4	24.2	42.5	33.0	42.6	28.3	31.4	37.3	35.5	40.8	48.4	25.0	52.0	32.4	29.5	87.6	26.1	56.3	86.1	47.3	20.7	34.9	55.4	24.0	56.8	40.4	39.6	50.5	24.0	37.4	35.6	44.9	39.3	69.1	24.8	17.2	34.2	48.6	89.0	77.8	41.9	81.5	86.4	58.1	79.6	66.2	72.0	98.2
SHCBP1	"FLJ22009, PAL"	ENSG00000171241	"SHC binding and spindle associated 1"	Q8NEM2	16	46580554-46621626	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.9;lymphoid tissue: 22.9;testis: 14.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA048876	Uncertain		Uncertain	"Nuclear bodies,Microtubules,Midbody,Mitotic spindle"				"Nuclear bodies"	"Microtubules, Midbody, Mitotic spindle"	"HPA048876: "	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.96e-4)"	"unprognostic (2.26e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (4.47e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.22e-16)"	"unprognostic (3.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.66e-1)"	1.5	0.8	1.0	17.3	3.0	18.9	0.9	2.4	1.3	0.8	2.2	0.6	0.3	1.3	1.5	2.0	5.7	0.4	1.1	1.5	1.0	0.7	5.0	0.3	1.7	11.2	0.7	0.7	1.2	0.3	0.2	0.8	2.8	0.7	0.9	2.5	0.3	2.6	0.3	1.4	3.8	2.3	1.9	1.1	9.9	1.4	14.1	0.9	22.9	0.6	3.0	12.9	2.0	1.6	4.6	2.0	1.8	5.4	0.3	3.4	2.1	15.2	16.2	6.1	7.4	1.3	3.1	8.5	31.0	12.2	30.4	14.1	7.7	10.0	13.3	14.0	14.1	10.1	13.4	10.1	37.6	8.5	9.0	14.6	12.2	13.1	0.0	12.8	18.7	0.6	0.6	22.3	9.0	15.9	6.0	14.1	32.9	10.1	11.5	10.7	4.8	17.3	21.0	41.1	21.3	6.2	4.7	2.6	3.3	21.4	11.4	4.9	6.2	10.5	9.1	22.3	14.4	21.4	24.6	11.2	14.8	21.4	10.2	13.9	22.4	0.3	0.8	1.8	0.5	1.3	0.1	4.6	0.8	0.4	1.2	1.9	0.1	0.3	0.8	0.3	5.4	2.0	3.4	2.1	1.0	3.0	2.4	1.3	1.0	0.7	0.7	0.7	0.7	0.9